NEW YORK — PMI Biopharma Solutions has partnered Nashville Biosciences to offer drug discovery and development services, the companies said on Friday.
Under the terms of the deal, the companies will offer Nashville Biosciences' genomic data and in silico technologies with PMI's lab and research services as a combined package for drug target identification and validation.